Revolution Medicines (NASDAQ:RVMD) Given New $145.00 Price Target at Needham & Company LLC
Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its price target reduced by equities research analysts at Needham & Company LLC from $150.00 to $145.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s price objective would indicate a potential upside of [...]